Stocks
iBio, Inc.IBIO
NASDAQHealthcareBiotechnology$0.76
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing plant-based biologic therapies for oncology and infectious diseases. Its proprietary technology platform uses engineered tobacco plants to produce therapeutic proteins, which differentiates it from traditional cell-based manufacturing. Investors track IBIO for its pipeline progress and potential cost advantages in biologic production.
52W Range: $0.73-$3.82
Congressional Interest in iBio, Inc. (IBIO)
No congressional trades have been disclosed for iBio, Inc. (IBIO) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading IBIO?
No congressional trades found for this stock.